Nanozyme-Based Lateral Flow Immunoassay (LFIA) for Extracellular Vesicle Detection

Nanozyme-Based Lateral Flow Immunoassay (LFIA) for Extracellular Vesicle Detection

Extracellular vesicles (EVs) are biological nanoparticles of great interest as novel sources of biomarkers and as drug delivery systems for personalized therapies. The research in the field and clinical applications require rapid quantification. In this study, we have developed a novel lateral flow...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Baihui Wang, Amanda Moyano, José María Duque, Luis Sánchez, Guillermo García-Santos, Luis J. García Flórez, Esther Serrano-Pertierra, María del Carmen Blanco-López
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: MDPI AG 2022-07-01
Sarja:Biosensors
Aiheet:
extracellular vesicles
iron oxide superparamagnetic nanoparticles (Fe<sub>3</sub>O<sub>4</sub> SMNPs)
lateral flow immunoassay (LFIA)
nanozyme
Linkit:https://www.mdpi.com/2079-6374/12/7/490

Internet

https://www.mdpi.com/2079-6374/12/7/490

Samankaltaisia teoksia